James D. Carroll

• 34 years photobiomodulation experience (since 1987).
• Founder and CEO, THOR Photomedicine
• Co-Founder, Investor, Lumithera Inc
• Co-authored 24 PBM papers and contributed chapters to 5 PBM books
• Bibliography https://publons.com/researcher/4374676/james-carroll/
• Recognised authority on PBM dose, dose-rate effects, and the measurement and reporting of parameters

APPOINTMENTS

• Biomedical Optics Society - conference co-chair (2009 - to-date)
• Fellow of The Royal Society of Medicine (2009 - to-date)
• Editorial Board of Photomedicine and Laser Surgery (2008 - 2013)
• World Association for Photobiomodulation Therapy (WALT)
• industry rep. (2000 - 2004) and industry rep. board member (2018 - to-date)
• North American Association for Laser Therapy board member (2002 - 2006)

NOTABLE SPEAKING EVENTS

• US Congressional briefing on PBM as a solution for the opioid crisis
• White House briefing on PBM as a solution for the opioid crisis
• United Nations Global Health Impact Forum on PBM for Dry AMD

AWARDS

• 2020 - World Association for Photobiomodulation Therapy, Presidential Commendation for service and leadership in the field of Photobiomodulation
• 2021 - T.H. Maiman Award for excellence in medical laser research